US Stock MarketDetailed Quotes

SPRY ARS Pharmaceuticals

Watchlist
  • 14.510
  • -0.020-0.14%
Close Nov 29 13:00 ET
  • 14.510
  • 0.0000.00%
Post 17:01 ET
1.41BMarket Cap-29020P/E (TTM)

ARS Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
2.07M
4,900.00%500K
0
-97.72%30K
0
0
-97.84%10K
-96.98%20K
-76.10%1.32M
0
Operating revenue
--2.07M
4,900.00%500K
--0
-97.72%30K
--0
--0
-97.84%10K
-96.98%20K
-76.10%1.32M
--0
Cost of revenue
112K
0
Gross profit
1.96M
0
Operating expense
31.85%23.7M
-23.16%15.84M
-29.58%13.19M
83.40%67.55M
-33.78%10.23M
163.65%17.98M
202.78%20.61M
141.34%18.73M
47.56%36.83M
15.44M
Selling and administrative expenses
28.75%19.28M
-32.78%8.94M
-34.67%7.96M
156.20%47.28M
-36.44%6.82M
411.83%14.98M
441.29%13.31M
420.78%12.18M
293.77%18.46M
--10.73M
-General and administrative expense
28.75%19.28M
-32.78%8.94M
-34.67%7.96M
156.20%47.28M
-36.44%6.82M
411.83%14.98M
441.29%13.31M
420.78%12.18M
293.77%18.46M
--10.73M
Research and development costs
47.34%4.42M
-5.64%6.9M
-20.12%5.23M
10.29%20.27M
-27.73%3.4M
-22.89%3M
68.00%7.31M
20.82%6.55M
-9.36%18.38M
--4.71M
Operating profit
-20.97%-21.75M
25.54%-15.34M
29.50%-13.19M
-90.11%-67.52M
33.78%-10.23M
-171.16%-17.98M
-224.76%-20.6M
-163.60%-18.71M
-82.56%-35.52M
-15.44M
Net non-operating interest income expense
Other net income (expense)
-15.81%2.62M
-12.65%2.82M
-22.71%2.9M
1,477.34%13.16M
201.58%3.06M
6,521.28%3.11M
4,353.95%3.23M
2,584.77%3.75M
205.70%834K
1.01M
Gain on sale of security
----
----
----
----
----
----
----
----
---140K
----
Other non- operating income (expenses)
-15.81%2.62M
-12.65%2.82M
-22.71%2.9M
1,250.62%13.16M
164.99%3.06M
6,521.28%3.11M
4,353.95%3.23M
2,584.77%3.75M
223.45%974K
--1.15M
Income before tax
-28.67%-19.13M
27.94%-12.52M
31.21%-10.29M
-56.75%-54.37M
50.32%-7.17M
-125.82%-14.87M
-170.56%-17.37M
-106.36%-14.96M
-71.33%-34.68M
-14.43M
Income tax
Net income
-28.67%-19.13M
27.94%-12.52M
31.21%-10.29M
-56.75%-54.37M
50.32%-7.17M
-125.82%-14.87M
-170.56%-17.37M
-106.36%-14.96M
-71.33%-34.68M
-14.43M
Net income continuous Operations
-28.67%-19.13M
27.94%-12.52M
31.21%-10.29M
-56.75%-54.37M
50.32%-7.17M
-125.82%-14.87M
-170.56%-17.37M
-106.36%-14.96M
-71.33%-34.68M
---14.43M
Minority interest income
Net income attributable to the parent company
-28.67%-19.13M
27.94%-12.52M
31.21%-10.29M
-56.75%-54.37M
50.32%-7.17M
-125.82%-14.87M
-170.56%-17.37M
-106.36%-14.96M
-71.33%-34.68M
-14.43M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-28.67%-19.13M
27.94%-12.52M
31.21%-10.29M
-56.75%-54.37M
50.32%-7.17M
-125.82%-14.87M
-170.56%-17.37M
-106.36%-14.96M
-71.33%-34.68M
-14.43M
Basic earnings per share
-25.00%-0.2
27.78%-0.13
31.25%-0.11
34.48%-0.57
54.43%-0.07
-127.91%-0.16
-162.91%-0.18
-106.94%-0.16
-303.00%-0.87
-0.1536
Diluted earnings per share
-25.00%-0.2
27.78%-0.13
31.25%-0.11
34.48%-0.57
54.43%-0.07
-127.91%-0.16
-162.91%-0.18
-106.94%-0.16
-303.00%-0.87
-0.1536
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 2.07M4,900.00%500K0-97.72%30K00-97.84%10K-96.98%20K-76.10%1.32M0
Operating revenue --2.07M4,900.00%500K--0-97.72%30K--0--0-97.84%10K-96.98%20K-76.10%1.32M--0
Cost of revenue 112K0
Gross profit 1.96M0
Operating expense 31.85%23.7M-23.16%15.84M-29.58%13.19M83.40%67.55M-33.78%10.23M163.65%17.98M202.78%20.61M141.34%18.73M47.56%36.83M15.44M
Selling and administrative expenses 28.75%19.28M-32.78%8.94M-34.67%7.96M156.20%47.28M-36.44%6.82M411.83%14.98M441.29%13.31M420.78%12.18M293.77%18.46M--10.73M
-General and administrative expense 28.75%19.28M-32.78%8.94M-34.67%7.96M156.20%47.28M-36.44%6.82M411.83%14.98M441.29%13.31M420.78%12.18M293.77%18.46M--10.73M
Research and development costs 47.34%4.42M-5.64%6.9M-20.12%5.23M10.29%20.27M-27.73%3.4M-22.89%3M68.00%7.31M20.82%6.55M-9.36%18.38M--4.71M
Operating profit -20.97%-21.75M25.54%-15.34M29.50%-13.19M-90.11%-67.52M33.78%-10.23M-171.16%-17.98M-224.76%-20.6M-163.60%-18.71M-82.56%-35.52M-15.44M
Net non-operating interest income expense
Other net income (expense) -15.81%2.62M-12.65%2.82M-22.71%2.9M1,477.34%13.16M201.58%3.06M6,521.28%3.11M4,353.95%3.23M2,584.77%3.75M205.70%834K1.01M
Gain on sale of security -----------------------------------140K----
Other non- operating income (expenses) -15.81%2.62M-12.65%2.82M-22.71%2.9M1,250.62%13.16M164.99%3.06M6,521.28%3.11M4,353.95%3.23M2,584.77%3.75M223.45%974K--1.15M
Income before tax -28.67%-19.13M27.94%-12.52M31.21%-10.29M-56.75%-54.37M50.32%-7.17M-125.82%-14.87M-170.56%-17.37M-106.36%-14.96M-71.33%-34.68M-14.43M
Income tax
Net income -28.67%-19.13M27.94%-12.52M31.21%-10.29M-56.75%-54.37M50.32%-7.17M-125.82%-14.87M-170.56%-17.37M-106.36%-14.96M-71.33%-34.68M-14.43M
Net income continuous Operations -28.67%-19.13M27.94%-12.52M31.21%-10.29M-56.75%-54.37M50.32%-7.17M-125.82%-14.87M-170.56%-17.37M-106.36%-14.96M-71.33%-34.68M---14.43M
Minority interest income
Net income attributable to the parent company -28.67%-19.13M27.94%-12.52M31.21%-10.29M-56.75%-54.37M50.32%-7.17M-125.82%-14.87M-170.56%-17.37M-106.36%-14.96M-71.33%-34.68M-14.43M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -28.67%-19.13M27.94%-12.52M31.21%-10.29M-56.75%-54.37M50.32%-7.17M-125.82%-14.87M-170.56%-17.37M-106.36%-14.96M-71.33%-34.68M-14.43M
Basic earnings per share -25.00%-0.227.78%-0.1331.25%-0.1134.48%-0.5754.43%-0.07-127.91%-0.16-162.91%-0.18-106.94%-0.16-303.00%-0.87-0.1536
Diluted earnings per share -25.00%-0.227.78%-0.1331.25%-0.1134.48%-0.5754.43%-0.07-127.91%-0.16-162.91%-0.18-106.94%-0.16-303.00%-0.87-0.1536
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data